Medicare contract · plan years 2026 and 2027CMS landscape and crosswalk
CareFirst Advantage Dsnp, Inc. (H8854)
H8854Contract
A company of CareFirst, Inc., sold as CareFirst BlueCross BlueShield Advantage DualPrime
1 plan in 2027 (1 in 2026) · 8,582 members in September 2026
CareFirst Advantage Dsnp, Inc. is the CareFirst, Inc. company that holds Medicare contract H8854, sold as CareFirst BlueCross BlueShield Advantage DualPrime. In 2027 it offers 1 plan (1 in 2026); every one of its 2026 plans continues in 2027. 8,582 people were in its plans in September 2026.
What plans does H8854 offer for 2027?
| Plan | Type | Monthly premium | Out-of-pocket limit | Area | For 2027 |
|---|---|---|---|---|---|
| CareFirst BlueCross BlueShield Advantage DualPrimeH8854-002 | HMO D-SNP | $5.70 | $9,850 | 24 counties | renews |
Source: CMS Medicare Advantage and Part D landscape files for 2027 (Sept. 22, 2026, revised Sept. 30) and 2026 (Sept. 2, 2026 revision); CMS plan crosswalk from 2026 to 2027 (Oct. 1, 2026).
How did CMS rate it for 2026?
The overall rating is 3.5 of 5 (health plan 3.5 of 5, drug plan 2.5 of 5). Of its 41 rated measures, the lowest and the highest:
| Lowest-rated measures | Stars |
|---|---|
| Transitions of Care | 1 |
| Medication Adherence for Diabetes Medications | 1 |
| Medication Adherence for Cholesterol (Statins) | 1 |
| MTM Program Completion Rate for CMR | 1 |
| Highest-rated measures | Stars |
|---|---|
| Medication Reconciliation Post-Discharge | 5 |
| Special Needs Plan (SNP) Care Management | 5 |
| Medication Adherence for Hypertension (RAS antagonists) | 4 |
| Rating of Drug Plan | 4 |
Source: CMS Part C and D Star Ratings data tables, 2026 (October 2025).
What else should you check?
- All CareFirst BlueCross BlueShield Advantage DualPrime plansEvery contract of the brand
- Star ratings of every contractThe 2026 ratings, and 2027 when CMS publishes them
- Find a plan by its IDFrom the card or a letter